Back
Results - Announcements
Sales rise 20.56% to Rs 73.29 crore
Balaxi Pharmaceuticals consolidated net profit declines 60.56% in the December 2024 quarter
11-Feb-2025, 07:32
Net profit of Balaxi Pharmaceuticals declined 60.56% to Rs 5.36 crore in the quarter ended December 2024 as against Rs 13.59 crore during the previous quarter ended December 2023. Sales rose 20.56% to Rs 73.29 crore in the quarter ended December 2024 as against Rs 60.79 crore during the previous quarter ended December 2023.
Net profit of Balaxi Pharmaceuticals declined 60.56% to Rs 5.36 crore in the quarter ended December 2024 as against Rs 13.59 crore during the previous quarter ended December 2023. Sales rose 20.56% to Rs 73.29 crore in the quarter ended December 2024 as against Rs 60.79 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 73.29 | 60.79 | 21 |
| OPM % | 5.44 | 22.47 | - |
| PBDT | 6.55 | 13.11 | -50 |
| PBT | 6.07 | 12.63 | -52 |
| NP | 5.36 | 13.59 | -61 |
Powered by Capital Market - Live News